Aldeyra Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aldeyra Therapeutics, Inc. on March 16, 2016. The report details actions taken by the Compensation Committee of the Board of Directors regarding executive compensation and the adoption of a new incentive plan for the twelve-month period ending December 31, 2016.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments and plan adoption.
Material Changes
The primary material change reported is the approval of 2016 annual base salaries and bonus target amounts for named executive officers, effective for the period ending December 31, 2016. Additionally, the Compensation Committee adopted a new Management Cash Incentive Plan.
Executive Compensation Details
| Name | Position | 2016 Base Salary | 2016 Target Bonus |
|---|---|---|---|
| Todd C. Brady, M.D., Ph.D. | President and CEO | $440,000 | $220,000 |
| Stephen J. Tulipano | Chief Financial Officer | $301,400 | $105,490 |
| Scott L. Young | Chief Operating Officer | $330,750 | $115,763 |
Management Commentary and Plan Terms
- Peer Analysis: Compensation decisions were based on an analysis of the Company's executive compensation compared to a peer group, conducted by Pearl Meyer & Partners.
- Incentive Plan: The new Management Cash Incentive Plan allows for performance-based cash bonuses for officers and employees.
- Discretion: The Compensation Committee retains discretion to increase, reduce, or eliminate bonuses based on actual performance and achievement of goals.
- Eligibility: Employees must remain employed by the Company at the time of payment to receive an award.
Investor Verification Checklist
- Review the full text of the Management Cash Incentive Plan filed as Exhibit 10.25 to understand specific performance objectives.
- Verify the total potential cash compensation exposure for the named executive officers.
- Confirm the peer group composition used by Pearl Meyer & Partners for the compensation benchmarking.
- Check subsequent filings for any adjustments to these compensation figures or the incentive plan terms.